Mr. R., 64, arrives with an anterior STEMI and is already in shock: systolic pressure in the 80s on norepinephrine, lactate rising, ejection fraction about 25% on echo. He is awake and following commands. His culprit artery has been opened, and he is in the cardiac ICU, still in shock on norepinephrine; a colleague suggests epinephrine, which constricts vessels and adds inotropy in one drug. The shock course follows him from the cath lab to the ICU; each trial answers one decision in his care.
This page helps you decide: Would epinephrine be a better first vasopressor for him?
After this page you can
Work through the six steps in order. Each question at the end belongs to one step, and the answer is on that step's page.
For Mr. R., epinephrine would not be a better first vasopressor: in OptimaCC it raised cardiac index no more than norepinephrine and brought more refractory shock (37% vs 7%, about one extra case for every 3 treated, on only 12 events), with a faster heart rate and lactic acidosis; keep norepinephrine, and add dobutamine if output stays low. On the one-pager it sits on page 2, in the “Vasoactive drugs — lowest dose, shortest time” table (Epinephrine row).